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Abstract
The intention of this review is to provide an overview of current methodologies employed in the rapidly
developing field of ocular proteomics with emphasis on sample preparation, two-dimensional polyacryl-
amide gel electrophoresis (2D-PAGE) and mass spectrometry (MS). Appropriate sample preparation
for the diverse range of cells and tissues of the eye is essential to ensure reliable results. Current methods
of protein staining for 2D-PAGE, protein labelling for two-dimensional difference gel electrophoresis,
gel-based expression analysis and protein identification by MS are summarised. The uses of gel-free
MS-based strategies (MuDPIT, iTRAQ, ICAT and SILAC) are also discussed. Proteomic technologies
promise to shed new light onto ocular disease processes that could lead to the discovery of strong novel
biomarkers and therapeutic targets useful in many ophthalmic conditions.
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1D One-dimensional
BME ß-mercaptoethanol
2D Two-dimensional
16-BAC Benzyldimethyl-n-hexadecylammonium chloride
AEBSF 4-(2-Aminoethyl) benzenesulphonyl fluoride
hydrochloride
AMD Age-related macular degeneration
ASB-14 Amidosulphobetaine-14
BCA Bicinchoninic acid
CD Cluster of differentiation molecule
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56CHAPS 3-[(3-Cholamidopropyl)dimethylammonio]-1-
propanesulphonate
CNBr Cyanogen bromide
CV Coefficient of variation
DIGE Difference gel electrophoresis alternatively
difference in gel electrophoresis
DTT Dithiothreitol
E-64 Trans-epoxysuccinyl-L-leucylamido(4-guanidino)
butane
EDTA Ethylene diamine tetraacetic acid
EGTA Ethylene glycol tetraacetic acid
ELISA Enzyme-linked immunosorbent assay
ESI Electrospray ionisation
FTICR Fourier transform ion cyclotron resonance
GFAP Glial fibrillary acidic protein
HEPES 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic
acid
ICAT Isotope-coded affinity tags
IEF Isoelectric focusing
IPG Immobilised pH gradient
IT Ion trap
iTRAQ Isobaric tags for relative and absolute
quantitation
kDa Kilodalton
LC Liquid chromatography
MALDI Matrix-assisted laser desorption ionisation
MDLC Multi-dimensional liquid chromatography
MS Mass spectrometry
MuDPIT Multi-dimensional protein identification
technology
NDSB-256 Dimethylbenzylammonium propane sulphonate
PAGE Polyacrylamide gel electrophoresis
PBS Phosphate-buffered saline
PDR Proliferative diabetic retinopathy
pI Isoelectric point
PMSF Phenylmethylsulphonyl fluoride
PTM Post-translational modification
Q Quadrupole
RPC Reverse phase chromatography
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RPMI Roswell Park Memorial Institute
RT-PCR Reverse transcription polymerase chain reaction
SB3-10 Sulphobetaine 10
SCX Strong cation exchange
SDS Sodium dodecyl sulfate
SILAC Stable isotope labelling with amino acids in cell
culture
TBP Tributylphosphine
TCA Trichloroacetic acid
TM Trabecular meshwork
TOF Time-of-flight
1. Introduction
Blindness and visual impairment can affect all manner and ages of
people. In 2002 the World Health Organisation estimated that
more than 161 million people were visually impaired around
the world of which 37 million were blind (1, 2). The consequen-
ces of blindness are devastating and wide-ranging on both the in-
dividual affected and society, leading to problems such as
unemployment in the young and social dependency of the elderly
(3). Sight-threatening disorders may be diagnosed and treated too
late to avoid significant loss of vision, and some have no effective
means of treatment or prevention at all. Ophthalmic proteomic
research promises to advance the management of many debilitat-
ing ocular disorders (4, 5).
Although the human genome has now been sequenced (6–8)
and a number of genes have been discovered that are linked with
diseases throughout the eye, a cell’s biological state is ultimately
dictated by proteins, the end products of the genes (9, 10). How-
ever, it is the understanding of how an estimated one million hu-
man proteins are encoded by approximately 25,000 genes that is
far from clear. Most genes are subjected to alternative splicing
following transcription resulting in the production of several
transcripts from each gene (10, 11). Furthermore, there appears
to exist a poor correlation between the RNA transcript level
and the abundance of the encoded protein, suggesting post-
transcriptional regulation (12, 13). Finally, the proteins them-
selves can undergo post-translational modification (PTM) which
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ic genome can give rise to an infinite number of dynamic pro-
teomes, and it is this proteome that alters with cell type and
state, which governs the phenotype at any particular moment
in time (11, 14).
Proteomics is able to qualitatively and quantitatively compare
protein profiles under different conditions to further explain bio-
logical systems and identify the disease markers that promise to
become the diagnostic and pharmaceutical targets of the future
(4, 5). Two-dimensional (2D) sodium dodecyl sulfate (SDS) poly-
acrylamide gel electrophoresis (PAGE) was first described in 1975
(15) and combined with mass spectrometry (MS) maintains its
place as one of the most effective technologies for proteomic anal-
ysis (14, 16, 17).
2D-PAGE separates proteins in two distinct steps. The pro-
tein mixture under study is initially applied to the first dimension
gel strip that separates according to charge through isoelectric
focussing (IEF). The strip is then applied to second dimension
SDS-PAGE where the proteins are further separated according
to their molecular masses (Fig. 1). The relatively small amounts
Fig. 1. Two-dimentional polyacrylamide gel (T—12%, C—3%; pH 3–10, non-linear gradient) of rab-
bit retinal tissue. Proteins are separated according to both their charge and their molecular mass.
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advantage for ophthalmic research where tissue can be limited (4).
Conventional biochemical techniques often study individual
proteins or isolated pathways; however, with 2D-PAGE,
thousands of proteins can be separated from a single sample in
a few steps. The proteins in the gels are then visualised with each
resulting spot ideally representing a single protein. These can be
studied with the aid of sophisticated computer analysis software
to determine the spots of interest to be identified, usually with
MS (14, 15, 17).
Proteins that have undergone PTM, for example phosphory-
lation or glycosylation, as well as the different forms arising from
alternative splicing can be detected by 2D-PAGE. The 2D-PAGE
technique is especially suited for resolving and visualising PTMs
since many of these cause a difference in both the charge and mass
of the protein (14, 18). These chemical and structural modifica-
tions may have an immense bearing on the protein’s function,
and are not apparent from genomic or transcriptomic studies
(9, 11, 16, 18).
Other methods of protein separation, involving electrophore-
sis, IEF and chromatography are available; however, here we
mainly focus on the core technology of 2D-PAGE, summarising
techniques specially optimised for the cells and tissues of the
eye. Rather than a detailed laboratory protocol, the purpose of
this article is to provide a methodological overview and useful ref-
erence to this scientific field.
2. General Sample
Preparation
The preservation of biological state and sample quality prior to
proteomic processing and analysis are extremely important. The
proteins should be protected against loss or change as a conse-
quence of proteolytic degradation. Ideally, ocular samples
s h o u l db es n a p - f r o z e ni nl i q u i dn i t r o g e ni m m e d i a t e l ya n d
stored at approximately −80°C until further use. In practise this
is not always possible, especially in a clinical setting. Therefore,
at the very least samples should be immediately placed on ice until
deep freezing which should not be delayed beyond approximately
30 min (19, 20). The use of specific protease inhibitors may also be
considered.
Cell disruption techniques are necessary when intracellular
proteins are being analysed. Depending on the sample type, cell
wall lysis can be induced by a variety of methods that include
the use of freeze–thawing, hyperosmotic solutions, ultrasonica-
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to 2D-PAGE separation with for instance, centrifugation or chro-
matography. These techniques allow specific organelles or groups
of proteins to be selected for optimised analysis, and allow less
abundant proteins to be more clearly resolved when complex cells
or tissue samples are being analysed such as those present in the
different components of the eye. In addition, the use of narrow
range immobilised pH gradient (IPG) strips (ultra-zoom gels)
increases the number of proteins that can be resolved, conferring
selection abilities in the first dimension (16, 21, 22).
Appropriate preparation of the sample is essential for 2D-
PAGE to produce reliable results. Ocular tissues and cells require
processing that should result in the complete solubilisation, dis-
aggregation, reduction and denaturation of the proteins (23).
The sample buffer generally consists of concentrated urea and
one or more detergents. Urea denatures the proteins for the first
dimension, unfolding the proteins and exposing all the ionisable
groups and prevents aggregation caused by hydrophobic interac-
tions. Urea is ideal since it has no effect on the native charge of the
proteins. Thiourea can be helpful if the proteins in a sample are dif-
ficult to solubilise. The denaturing effects of the sample solution
itself is often able to prevent the action of many proteases, although
as previously mentioned specific protease inhibitors may also be in-
dicated (21–24).
The sample solution also includes carrier ampholines or IPG
buffers that enhance protein solubilisation and can increase pre-
cipitation of unwanted nucleic acids during centrifugation. Other
additions include reducing agents, commonly dithiothreitol
(DTT) or β-mercaptoethanol (BME), which disrupt disulphide
bridges to allow full denaturation of the proteins (21, 24).
Membrane proteins have been shown to account for a signif-
icant proportion of human proteins and drug targets (25). These
proteinsareinvolvedinawiderangeofimportantcellularprocess-
esthatincludesignaltransduction,transport(proteins,hormones,
ions and metabolites) and cell division. For example, the visual
pigment rhodopsin is a G-protein-coupled (transducin) receptor
that comprises seven transmembrane helices. Mitochondrial
membrane proteins such as cytochrome c oxidase are vital for
many of the key functions of the mitochondrion that include ox-
idativephosphorylation,regulationofcellularmetabolismandap-
optosis.However,theseinherentlyhydrophobicproteinscanpose
aparticularchallengefor2D-PAGEasaresultoftheirlowsolubil-
ity and tendency to aggregate, and many sample preparation pro-
tocols have been developed to specifically address this issue with
varying success. The use of the cationic detergent 16-BAC in
the first dimension followed by the anionic SDS detergent in
the second dimension has been shown to improve 2D resolution
of hydrophobic proteins (25–27).
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Preparation
In addition to the general sample preparation points discussed
above, each of the individual parts of the eye require a more em-
pirical approach. Although ideal ocular sample preparation meth-
ods for proteomic analysis are not presently clearly defined, here
we offer an insight into practises that have worked well.
3.1. Cornea The cornea can be processed as a whole or separately by each of
its anatomical components (epithelium, basement membrane
zone, stroma, Descemet’s membrane and endothelium).
Thompson et al. (28) investigated the proteomic changes of
rat corneas following angiogenesis induced by silver nitrate-
cautery. They harvested 60 rat eyes and dissected their cor-
neoscleral rims. The tissue was solubilised in sample buffer by
grinding with a liquid-nitrogen-chilled mortar and pestle, before
centrifugation (28, 29). The sample buffer consisted of 9 M
urea, 2% CHAPS, 2% DTT, 0.1% SDS, trace bromophenol blue
in addition to a 0.5 tablet/ml of Complete Protease Inhibitor
Cocktail (Roche, Basel, Switzerland). This protease inhibitor
works against many proteases including cysteine-, serine- and
metalloproteases. Following centrifugation to remove particulates,
an IEF buffer (9 M urea, 2% CHAPS, 2% DTT, 1% Pharmalyte,
pH 3–10) was added before loading onto IPG stips, pH 4–7. The
2D 10% polyacrylamide gels were silver stained without
glutaraldehyde during fixation in order to prevent the problem
of protein cross linkage which can impede MS-based identifica-
tion. This optimised preparation for rat corneas was consistently
able to produce high-quality 2D-gels for protein visualisation,
analysis and subsequent mass spectrometric identification. Indeed,
over 100 proteins were shown to change their expression in re-
sponse to cauterisation.
This research group performed a study on potential markers
of keratoconus (30). Human corneal epithelial cells were isolated
from patients shortly before undergoing corneal transplantations.
The central 8 mm of the patient’s cornea was coagulated with ab-
solute ethanol and washed in PBS. The epithelium was then gent-
ly scraped off with a scalpel and quickly dissolved in 4 M
guanidine thiocyanate (dissolved in 25 mM citrate, 0.5% lauroyl-
sarcosine and 100 mM BME), followed by immediate snap-freez-
ing in liquid nitrogen (30, 31). Two different sample preparation
protocols were used; direct addition of lysis buffer (9 M urea, 2%
Triton X-100, 0.13 M DTT and 2% IPG buffer), or pre-treatment
with the ready-to-use reagent RNAzol B (Wak Chemie Medical,
Steinbach, Germany). The pre-treated samples homogenised
and lysed in the RNAzol B solution (phenol and guanidine thio-
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the addition of chloroform. Subsequent centrifugation was then
used to remove the protein from the aqueous containing RNA.
The proteins were precipitated by the mixing of two volumes of
ice-cold 99.9% ethanol. After incubation on ice for 1 h, samples
were centrifuged at 14,000×g for 10 min. The supernatant con-
taining RNA was discharged whilst the pellet was dissolved in the
lysis buffer mentioned. The IEF buffer consisted of 8 M urea,
0.02 M CHAPS, 0.02 M DTT and 2% IPG buffer, using non-
linear IPG strips, pH 3–10. Six percent and 12% polyacrylamide
gels were utilised for the second dimension separation to accom-
modate a greater range of molecular masses with silver staining
revealing hundreds of resolved proteins. It was readily apparent
that there was far less smear and background staining on the gels
loaded with the RNAzol-B-treated protein samples. To check
for loss of proteins in the RNA-depleted samples, the chloroform
phase and RNA-containing aqueous phase were run for 2D-
PAGE analysis. Abundant proteins were also found in the aque-
ous buffer to some extent. In addition, on direct comparison of
the 2D-gels with samples directly lysed in buffer and those pre-
treated for RNA removal, there were a few proteins that were
not represented in either group. Overall, RNA removal was ef-
fective in producing 2D-gels with less streaking which would
help to resolve, analyse and identify certain proteins; however,
this led to the unintentional removal of some others.
Aside from nucleic acids, there are other interfering substan-
ces that can cause problems with 2D-PAGE. For instance, high
salt concentrations may affect protein solubility and impair electri-
cal current during IEF. Jurkunas et al. (32) attempted to avoid
this difficulty in their proteomic study of human corneal endothe-
lial cells affected by Fuchs’ endothelial dystrophy by subjecting
the cells to an additional washing step with HEPES buffer. The
primary protein buffer added to the samples consisted of 5 M
urea, 2 M thiourea, 2% CHAPS, 2% SB3-10, 40 mM Tris, 0.2%
ampholyte (pH 3–10) and 1 mM TBP. IEF was undertaken on
IPG strips, pH 3–10. A preliminary study of pooled samples con-
firmed the reproducibility of their 2D protein separation, and the
8–16% precast polyacrylamide gels (Bio-Rad, Hercules, USA)
stained with SYPRO ruby in the final study were of very high
quality for subsequent image analysis. Although the extra washing
step to remove salt was rather simple, it does not imply that it is
less effective than other more sophisticated techniques such as
protein precipitation, ultra filtration and dialysis, which have been
shown to cause significant protein loss (22).
Karring et al. (33) conducted a proteome analysis of normal
intact human corneas using a variety of protocols to optimise ex-
traction and separation of proteins. For 2D-PAGE and MALDI-
MS analysis, water-soluble proteins were extracted from corneal
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ing a cocktail of protease inhibitors (2 mM EDTA, 2 mM 1, 10-
phenanthroline, 40 μM E-64 and 2 mM AEBSF). However, the
proteins found on the silver stained 12.5% 2D-gels were largely
the same as those extracted using a more standard lysis buffer
(5 M urea, 2 M thiourea, 2% CHAPS, 2% SB3-10, 10 mM
DTT, 2 mM EDTA, 2 mM 1,10-phenanthroline, 40 μM E-64,
2 mM AEBSF, 0.5% IPG buffer of pH 3.5–5.0, 4–7o r6 –11
and bromophenol blue).
To facilitate the identification of insoluble proteins and those
at the extremes of molecular mass and isoelectric point (pI),
K a r r i n ga n dc o l l e a g u e su s e dC N B rt oc h e m i c a l l yd i g e s tt h e
cornea followed by trypsin digestion to produce peptides suit-
able for liquid chromatography (LC)–electrospray ionisation
(ESI)–MS/MS analysis. However, only around 30 proteins were
identified using this method. The authors postulated that this
was due to the large number of peptides derived from highly
abundant proteins such as collagens. In an effort to overcome
this problem proteins were fractionated by 1D-PAGE prior to
tryptic digestion, which led to over 100 identifications with
LC-ESI-MS/MS. However, they found that this method was
not suitable for proteins at the extremes of molecular mass or
proteins such as collagen that are not soluble in SDS sample
buffer. All in all, 141 distinct proteins were identified with many
that were never previously found in the mammalian cornea using
direct identification methods (33).
3.2. Conjunctiva Shimmura et al. (34) performed 2D-PAGE comparisons of the
supernatants from cultured conjunctival, limbal and central corneal
fibroblasts in a search for stem cell markers. Supernatants were
placed in ultra filtration tubes and centrifuged so that proteins of less
than 3 kDa were removed and those above concentrated. The lysis
buffer consisted of 8 M urea, 2% Nonidet P-40, 2% ampholine
(pH 3.5–10), 5% BME and 1 tablet/10 ml Complete Mini
EDTA-free protease inhibitor (Roche, Basel, Switzerland). IEF
was performed using a disc gel, pH 3.5–10 (Nihon Eido, Tokyo, Ja-
pan) followed by second dimension separation upon a 16.8% poly-
acrylamide gel. The proteins were then visualised with Coomassie
brilliant blue staining. Since the supernatant was relatively low in
protein levels compared to the pelleted cells, some of the 2D-gels
could not be analysed despite condensing the samples. Precipitation
techniques are an alternative method of protein concentration.
3.3. Sclera Sclera is a fibrous connective tissue that can prove especially difficult
for protein extraction. Patel and colleagues (35) studied a variety of
protocols to optimise protein extraction primarily from porcine scler-
al tissue for 1D-PAGE (LC-ESI-MS/MS). The authors found that
the recently developed technique of pressure cycling was able to re-
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ods of homogenisation. Pressure cycling was performed for 60 cycles
of 20 s at 35,000 psi followed by a sudden drop to atmospheric pres-
sure, maintained for 5 s. Protein recovery was estimated using Brad-
ford’s method. Pressure cycling was able to extract more protein in
the posterior sclera, compared to anterior or peripapillary sclera, sug-
gesting regional variations in scleral protein composition. Further-
more, aqueous-organic phase partitioning was found to improve
separation and resolution on SDS-PAGE. The authors also investi-
gated the effects of a variety of ionic, non-ionic and zwitterionic
detergents upon different regions of the porcine eye using both
Bradford’s and BCA protein assays. The combination of 0.5% Triton
X-100, 0.5% Tween-20 and 0.1% Genapol C-100 was shown to in-
crease protein extraction from the sclera.
Lu et al. (36) performed 2D-PAGE upon normal anterior and
posterior human scleral fibroblasts. Cells were cultured, ultrasoni-
cated and centrifuged. The resultant supernatant containing the
solubilised protein was mixed in 8 M urea, 2% CHAPS, 20 mM
DTT, 0.5% IPG buffer and bromophenol blue. IEF was undertaken
with IPG strips, pH 3–10 and 12% polyacrylamide gels were utilised
for the second dimension. The Coomassie-R250 stained gels were
of high quality, resulting in 455 and 453 protein spots from anterior
and posterior scleral fibroblast samples respectively, with 19 spots
demonstrating a fivefold or more level of differential expression on
analysis.
3.4. Trabecular
Meshwork
Proteomic analysis of the trabecular meshwork (TM) has been
primarily studied in an effort to further define the role of this
structure in glaucoma pathophysiology (37–41). Indeed, the
TM is the main site of resistance to the outflow of aqueous hu-
mour from the eye.
Zhang and colleagues (37) undertook a 2D-PAGE compari-
son of the membrane extracts of normal and glaucomatous TM
cells. Normal TM tissue was obtained from five human donor eyes
within 24 h of death and isolated under microscopic dissection.
TM from five primary open-angle glaucoma patients was acquired
within 1 h following standard surgical trabeculectomy. TM cells
were cultured in Dulbecco’s modified Eagle’s medium with 10%
foetal bovine serum, 2 mM glutamine and antibiotics maintained
at 37°C in 5% CO2. Membrane and cytoplasm TM cell extracts
were obtained by centrifugation of the TM cells at 1,500×g for
5 min before resuspension in lysis buffer (50 mM tris/HCL,
pH 7.4, 1% Triton X-100 and 1% protease inhibitor cocktail) fol-
lowed by liquid nitrogen freezing and thawing at room tempera-
ture. A cytoplasmic supernatant was obtained by centrifugation at
200,000×g for 45 min. The pellets were washed in ice-cold lysis
buffer and resuspended in ice-cold 100 mM Tris/HCL
(pH 7.4). The supernatant was then centrifuged at 50,000×g
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in 100 mM Tris/HCL (pH 7.4). Membrane samples (100 μg)
were dissolved in 7 M urea, 2 M thiourea, 4% CHAPS, 20 mM
Tris, 10 mM DTT, 0.2% ampholytes (pH 3–10) and a trace of
bromchlorphenol blue before IEF, upon IPG strips, pH 3–10.
Second dimension separation was undertaken on 13% polyacryl-
amide gels and was repeated in parallel at least three times for each
sample. Following silver staining, 11 differentially expressed pro-
tein spots were found on the high quality 2D-gels.
3.5. Aqueous Humour This research group performed a proteomic analysis of aqueous
humour from patients with acute corneal graft rejection prior to
any treatment (42). Aqueous from cataract surgery patients with
no other ocular conditions served as controls. IEF was performed
with IPG strips pH 3–10. Preliminary trials indicated that 5 and
45 µL of aqueous humour were found to give the highest resolu-
tion of silver-stained protein spots in the 40–220 and 15–40 kDa
molecular mass range, respectively. Therefore, both 6% and 12%
polyacrylamide gels were used for second dimension separation.
Samples were solubilised directly in a lysis buffer of 8.9 M urea,
2% Triton X-100, 2% IPG buffer and 0.13 M DTT. The IEF re-
hydration solution consisted of 8 M urea, 0.02 M CHAPS, 2%
IPG buffer and 0.02 M DTT. Approximately 950 different pro-
tein spots were resolved across the 15–220 kDa range, with 31
spots found to be at least twofold differentially expressed.
Another study, performed by Duan et al. (43), undertook
2D-PAGE analysis upon aqueous humour of patients with high
myopia using a protocol adapted from our studies (42). Aqueous
humour samples of 45 µL were solubilised in lysis buffer of 8 M
urea, 4% CHAPS, 0.5% IPG buffer and rehydrated in 8 M urea,
2% CHAPS, 1% IPG buffer and 0.1 M DTT. First dimension
IEF was performed with IPG strips pH 3–10 and second dimen-
sion separation was undertaken with 12% polyacrylamide gels.
The final silver-stained 2D-gels proved to be of high quality with
analysis revealing six protein spots at least twofold differentially
expressed.
Grus and colleagues (44) analysed aqueous humour from
patients with primary open-angle glaucoma and noted a similar
protein profile to our study (42). Their preliminary studies found
the highest resolution of spots using 30 µL of aqueous humour
with IPG strips pH 4–7 and 13.5% 2D polyacrylamide gels.
Sample preparation was based on their previous 2D-PAGE studies
of tears (45). Aqueous humour was mixed with 8 M urea, 2%
CHAPS, 0.28 DTT, 0.5% IPG buffer and 0.002% bromophenol
blue before loading onto IPG strips. Approximately 225 proteins
spots were resolved between a 10 and 80 kDa range on the silver
stained gels, with results that were verifiable with protein chip
arrays and ELISA.
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tumour in adults (46). There is much interest in understanding the
pathogenesisofthisdiseasewithaviewtodifferentiatingfavourable
and unfavourable tumours in terms of growth and metastasis (47).
Proteomic 2D-PAGE studies were recently applied to cell lines
from primary uveal melanoma (48) and cell lines originating from
the hepatic metastases (49). In both studies the human uveal mel-
anomacellsweresimilarlyculturedinRPMImediumwith10%foe-
tal bovine serum, 2 mM glutamine and antibiotics at 37°C in a 5%
CO2atmosphere.Pardoetal.(48)endeavouredtoobtainaproteo-
mic cell map of uveal melanoma. To disrupt the cells, sonication
was performed in a lysis buffer of 5 M urea, 65 mM CHAPS,
0.15MNDSB-256,1mMsodiumvanadate,0.1mMsodiumfluo-
ride and 1 mM benzamidine. Following centrifugation the super-
natant was removed, and 600 µg of protein was added in 375 µL
of lysis buffer with IPG buffer. IEF was undertaken on four IPG
strips, pH 3–10. The investigators chose to use a broad pI range
3–10 rather thanzoom gelsin aneffort toobtaina globalrepresen-
tation of the proteins. Approximately 1,150 protein spots were re-
solved in total on the 9–16% polyacrylamide gradient gels stained
with the fluorescent dye OGT MP17, with around 85%
reproducible across at least three of the four gels. Random excision
and subsequent MS of 270 spots over the range of spot intensities
yielded 683 distinct proteins.
Thisresearchgrouphasrecentlyperformed2D-PAGELC-ESI-
MS/MSanalysis uponhuman uveal melanoma tissue withmonoso-
my and disomy 3. Direct analysis of the tissue provides another
window through which to view this tumour proteome (50).
3.7. Lens The crystallins constitute more than 90% of total lenticular protein
(51, 52). These water-soluble structural proteins undergo many
PTMs throughout life, some of which may be required for their
long-term functionality, whilst others can result in their aggrega-
tion and decreased solubility that may lead to lens opacification
(52, 53). The 2D-PAGE method is able to allow detection and
visualisation of proteins irrespective of PTM and may therefore
be particularly useful for lens analysis (54). Like the cornea, the
lens can either be analysed in its entirety or dissected into its cap-
sule, cortex and nucleus (and further subdivisions). Suitable sam-
ple preparation will also depend on the health and age of the lens
under investigation (52).
Harrington et al. (55) divided lenticular matter into water sol-
uble (WS) and insoluble (WI) portions, and further divided the
WI into urea soluble (US) and insoluble (UI), prior to 2D-PAGE
comparative study of normal and cataractous human lenses. A
healthy lens and another with nuclear cataract were retrieved
within 48 h following the death of a 68-year-old subject and 4–
5 h following surgery in a 61-year-old subject, respectively. Lenses
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Each lens was decapsulated and suspended in a buffer of 50 mM
Tris–HCl, pH 7.9, 1 mM DTT, 1 mM iodoacetamide (cysteine
proteinase inhibitor) and 1 mM phenylmethylsulphonyl fluoride
(PMSF; serine proteinase inhibitor). The investigators also used
iodoacetamide for its ability to alkylate sulphydryl groups. The
lens was homogenised in the sample solution using a tissue grind-
er before centrifugation at 15,000×g for 15 min. The supernatant
was removed and the pellet rehomogenised and repeat centri-
fuged twice. The supernatants accounted for the WS protein frac-
tion whilst the WI protein fraction was retained in the pellet. The
WI fraction was suspended in 50 mM Tris–HCl, pH 7.9, 6 M
urea and 5 mM DTT, and further homogenised and centrifuged.
The resulting supernatants accounted for the water-insoluble–
urea-soluble protein fraction (WI-US), and the pellet as the
water-insoluble–urea-insoluble (WI-UI) protein fraction. Aliquots
of 500–800 µg of WI-US and WI-UI lens protein were resolubi-
lised in 5 M urea, 2 M thiourea, 2% CHAPS, 2% SB3-10, 2 mM
TBP, 40 mM Tris, pH 8.0 before loading onto IPG strips,
pH 3–10. The second dimension was undertaken upon 15% poly-
acrylamide gels, which were subsequently stained with Coomassie
blue. Analysis revealed significant protein differences between the
healthy and cataractous lenses, and between the WI-US and WI-
UI proteins.
In another similar study Posner and colleagues (56)u t i l i s e d
2D-PAGE to characterise the PTMs of the crystallins and obtain
a proteome map in the zebrafish lens. Zebrafish adult lenses were
homogenised in 8 M urea, 2% CHAPS, 50 mM DTT, 0.2%
Bio-Lyte ampholyte pH 3–10 and 0.001% bromophenol blue.
Following centrifugation at 15,000×g for 20 min, 150 µg of lens
homogenate was focused on IPG strips at pH 3–10, 5–8 and 4–7.
Another set of lenses were homogenised in 20 mM sodium phos-
phate also containing a protease inhibitor (Roche, Basel, Switzer-
land) and centrifuged to produce a soluble supernatant protein
fraction and insoluble pellet fraction. Using the Bradford method
150 µg of each protein fraction was diluted in the above stated
buffer and applied to IPG strips, pH 5–8. In all cases second di-
mension separation was undertaken on 12% polyacrylamide gels,
which were subsequently Coomassie stained. Over 80 protein
spots were resolved on the high-quality gels, the majority being
the crystallins and their PTMs. Furthermore, certain crystallins
especially truncated versions were found to be more abundant
in the insoluble fraction.
3.8. Vitreous Body There have been a number of vitreous 2D-PAGE studies for condi-
tions such as uveitis (57, 58) and diabetic retinopathy (59–62). An
importantissuetoconsiderwithvitreousinparticularistheproblem
of highly abundant proteins such as albumin and immunoglobulin
68 Mandal et al.possibly preventing the detection of lower abundant proteins (63,
64). Kim and co-workers (62) attempted to deplete certain proteins
known to be highly abundant in biological fluids such as human
plasma from patient vitreous samples as part of their proteomic
study of proliferative diabetic retinopathy (PDR) involving
2D-PAGE. This was achieved with the immunoaffinity subtrac-
tion system, ProteomeLab IgY-12 spin column (Beckman
Coulter, Fullerton, CA, USA) which aims to only remove: al-
bumin, IgG, transferrin, fibrinogen, IgA, α2-macroglobulin,
IgM, α1-antitrypsin, haptoglobin, orosomucoid, apolipoprotein
A-I and apolipoprotein A-II from the sample. However, Liu
and co-workers (65) evaluated this system and found that other
proteins were also depleted from the sample, though when this
occurred it was reproducible.
The low abundant proteins are obtained in the flow-through
fraction whilst the 12 high abundant proteins are resin antibody
bound within the column. The bound proteins were retrieved
with the use of stripping (1 M glycine–HCl, pH 2.5) and neutral-
isation buffers (1 M Tris–HCl, pH 8.0). Both protein fractions
were subsequently dialysed with the Slide-A-Lyzer (Pierce, Rock-
ford, IL, USA) in an effort to remove salt and small molecules less
than 3.5 kDa. The desalted protein samples were precipitated
with TCA in acetone and centrifuged. The supernatant was dis-
carded and the dried pellet rehydrated in 7 M urea, 2 M thiourea,
2% CHAPS, 60 mM DTT and IPG buffer, pH 3–10. IEF was un-
dertaken on IPG strips, pH 4–7. Second dimension separation
was undertaken on 10% polyacrylamide gels that were subse-
quently silver stained.
The low abundant protein fraction yielded 47 2D-gel spots
for analysis, with only six spots able to be identified by
MALDI-MS. Three of the six spots were identified as albumin.
The authors explained that this very low protein spot identifica-
tion might either be due to low protein spot concentration or
low yields of low abundant protein. The high abundant protein
gels resolved 116 spots with 87 successfully identified, most as
expected being albumin in addition to transferrin, haptoglobin,
apolipoprotein and α1-antitrypsin.
2D-PAGE analysis was also conducted on non-immunoaffin-
ity-subtracted PDR vitreous. This yielded 69 spots for excision of
which 54 spots were identified as 28 different proteins.
In effort to increase the number and diversity of protein iden-
tifications Kim and colleagues (62) employed 1D-fractionation
and tandem MS using two ionisation methods. In this case only
albumin and IgG were depleted from the vitreous using a Pro-
teoExtract albumin/IgG removal kit (Calbiochem, San Diego,
USA). With LC-MALDI-MS/MS fifty-four proteins were identi-
fied in the albumin/IgG depleted PDR vitreous and 49 proteins
in the non-depleted PDR vitreous. However, LC-ESI-MS/MS
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and 136 proteins in the non-depleted PDR vitreous.
3.9. Neurosensory
Retina
There is great interest in the protein changes of the neurosensory
retina affected by diabetic retinopathy (66–68) and age-related
macular degeneration (AMD) (69) the leading causes of blindness
in the working age and elderly population, respectively. Ethen et
al. (69) utilised 2D-PAGE to compare the proteome of central
and peripheral neurosensory retina at different stages of AMD.
Post-mortem eyes were snap-frozen in liquid nitrogen and stored
at −80°C. The vitreous was removed whilst the eyes were still
frozen to minimise contamination of the neurosensory retina.
An 8-mm trephine punch was used to separate the macula from
the peripheral retina. The neurosensory retina was then carefully
peeled from the retinal pigment epithelium (RPE) and rinsed in
PBS to minimise RPE cell contamination. Samples were homo-
genised in a medium containing 20% sucrose, 20 mM Tris–acetate
(pH 7.2), 2 mM MgCl2, 10 mM glucose and 2% CHAPS. The
homogenate was centrifuged and the supernatant retained. The
resultant pellet was rehomogenised, centrifuged and the super-
natant removed. Both supernatants were combined and 150 µg
of retinal protein was processed for 2D-PAGE analysis. IEF was
p e r f o r m e dw i t hI P Gs t r i p s ,p H5 –8 that were equilibrated for
10 min in 6 M urea, 2% SDS, 375 mM Tris–HCL (pH 8.8), 20%
glycerol and 130 mM DTT, followed by 10 min in the same buffer
with 135 mM iodoacetamide substituted for DTT. Analysis of the
12% polyacrylamide silver-stained gels revealed 584 and 524 well-
resolved protein spots in the macula and peripheral neurosensory
retina respectively, with 26 candidate proteins identified as being
possibly related to the onset and progression of AMD.
This research group has performed 2D-PAGE on the neuro-
sensory retina from a patient afflicted with Leber’sc o n g e n i t a l
amaurosis (LCA) (70). Immediately after enucleation the eye
was divided along the horizontal meridian and a 4×4-mm section
of neurosensory retina was carefully excised from the underlying
RPE. The retinal anatomical location and area were matched to
that of the seven normal controls to ensure standardised samples
for optimal comparison. Samples were added to a lysis buffer
consisting of 9 M urea, 2% DTT, 2% Triton X-100 and 2% IPG
buffer. The IPG strips, pH 3–10 were rehydrated in 400 µL of
buffer containing approximately 100 µg of protein in 8 M urea,
2% CHAPS, 0.3% DTT and 2% IPG buffer. Second dimension
separation was undertaken on 15% polyacrylamide gels that were
subsequently silver stained using a glutaraldehyde-free fixation
method. Four differentially regulated proteins were identified as
being possibly associated with LCA pathogenesis. Scleral tissue
was used as an additional control since it is not thought to be in-
volved in the pathology of LCA. Indeed, there was no significant
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obtained from the LCA and normal eye.
3.10. Retinal Pigment
Epithelium
There have been a number of proteomic studies of the RPE (71–
76) and the extracellular deposits that can accumulate beneath
this cellular layer termed drusen, which are associated with the de-
velopment of AMD (77, 78). Using 2D-PAGE Nordgaard et al.
investigated the global (71) and mitochondrial proteome (72)
of RPE cells at different stages of AMD, complimenting the
groups retinal studies (69). After removal of the neurosensory ret-
ina, calcium- and magnesium-free phosphate-buffered saline was
used to moisten the RPE cells to assist dislodgement from the un-
derlying choroid. The cells were centrifuged at 1,100×g for
30 min and fractionated in 50 mM Tris (pH 7.8) and 2% CHAPS
by freeze–thaw cycles and mechanical homogenisation. The lysate
was centrifuged for 600×g for 15 min to pellet cell debris. Ace-
tone precipitation was used to remove lipids and nucleic acids be-
fore the samples were resuspended in 8 M urea and 0.5% CHAPS.
The protein concentration was determined and 140 µg of RPE
protein was separated in the first dimension upon IPG strips,
pH 5–8. Second dimension electrophoresis was undertaken with
12% polyacrylamide gels as described previously (69). Approxi-
mately 440 protein spots were clearly resolved and analysed on
the silver-stained gels (71).
The degree of RPE protein contamination with retinal photo-
receptoroutersegment(RPOS)wasdeterminedbyquantifyingthe
RPOS protein that was copurified with the RPE. The RPE cells
were harvested, pelleted and resuspended in PBS as described
above. The sample was subsequently layered over a 25% to 60%
continuous sucrose gradient before centrifugation at 75,000×g
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gradient and brought up in 10–15 mL of 10 mM Tris and further
centrifuged at 17,369×g for 30 min. The total RPOS protein
amount was calculated as a percentage of the total protein yield
from the correspondingsample, which on average was only around
5%. In addition, analysis revealed no linearity between AMD stage
anddegreeofRPOScontaminationsuggestingthatthecontamina-
tion did not vary between the different AMD grades (71).
Nordgaard and colleagues (72) undertook a further 2D-
PAGE analysis of the subproteome of enriched RPE mitochondria
associated with different stages of AMD. RPE cells were homoge-
nised in 0.5% Nonidet P-40, 1 mM PMSF, 20 mM HEPES
(pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 250 mM sucrose
1 mM EDTA and 1 mM EGTA. The homogenised tissue was
freeze–t h a w e dt w i c ea n dt h et i s s u es u s p e n s i o np a s s e dg e n t l y
through a 26-gauge needle six times. Centrifugation at 600×g
for 15 min cleared the lysate of nuclei and intact cells. The super-
natant was retrieved, pellet rehomogenised and centrifuged. The
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were pelleted from the lysate by centrifugation at 13,000×g for
15 min. The pellet was then resuspended in 8 M urea, 2% CHAPS
and 0.5% ASB-14. In an effort to increase the solubility of the
membrane bound proteins, the mitochondrial fraction underwent
two freeze–thaw cycles and incubation in a water bath sonicator
for 30 min. Antibody probing for GFAP and CD34 antigens sug-
gested little or no contamination of the mitochondrial samples
with retina or choroid, respectively. 2D-PAGE was undertaken
with 100 µg of mitochondrial protein loaded onto IPG strips,
pH 3–11. Second dimension separation was performed with
12% polyacrylamide gels that were subsequently silver stained
for protein spot visualisation. Approximately 440 protein spots
were resolved in each gel, and the 222 spots that were consistently
resolved were further analysed revealing eight differentially
expressed spots.
4. Methods
of Protein
Visualisation
4.1. Protein Staining To visualise the proteins in the gels, they must be stained or la-
belled. This is a vital step of the 2D-PAGE procedure with regard
to the number, quantitation and subsequent comparison of pro-
teins spots (79). Indeed, it is the detection of resolved proteins
rather than the degree of protein resolution that is a common
limitation with proteomic analysis by 2D-PAGE (80). A protein
stain should bind irrespective of the protein’s composition, rela-
tive hydrophobicity or ability to bind SDS, and work reproducibly
over a broad range of protein concentrations without interfering
with them so that subsequent analysis such as Edman sequencing
or MS identification is not compromised (81). In this section, we
giveasummaryofthecommonlyusedcolourimetricandfluorescent
dyes for ocular protein staining.
The most widely used dyes are Coomassie Brilliant Blue and
silver nitrate. The sensitivity (100 ng) and specificity (high-back-
ground staining) of Coomassie may remain a problem despite the
improved colloidal version; however, it is cost-effective, relatively
simple to use and offers good compatibility with MS (11, 80–84).
In addition, the application of infrared fluorescent detection rather
than standardmethodshas beenshowntosignificantlyincrease the
sensitivity obtainable from colloidal Coomassie staining (80, 85).
Silver nitrate offers excellent sensitivity (1–10 ng) and ease of
use at a relatively low cost; however, the narrow linear dynamic
range of silver, saturation of high abundance proteins and also
negative staining of strong spots, can make relative quantitation
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aldehyde fixation for instance, which can cause covalent modifica-
tion of proteins, in-gel digestion and peptide recovery necessary
for MS-based protein identification can be impeded (86–88). In-
deed, there are over 150 published silver-staining protocols which
aim to solve these problems whose success also depends upon
which MS ionisation method is subsequently used (22, 89–91).
Ammoniacal silver nitrate staining may also be a viable choice in
certain situations (92, 93) as well as other recently developed
modifications (94). A technique of note is the modified colloidal
Coomassie Blue stain also known as blue silver, since it is reported
to offer a sensitivity approaching that of silver with good compat-
ibility with MS (95).
There are several fluorescent stains in use and most are simple
to employ. Of these the SYPRO Ruby stain is considered one of
the most effective and commonly used (80). SYPRO Ruby has a
sensitivity similar to silver nitrate, with a broad linear dynamic
range (three orders of magnitude) and very good compatibility
with in-gel digests for MS (86, 88). However, protein detection
with SYPRO Ruby has been shown to have some degree of vari-
ance from protein to protein (96). In addition, SYPRO Ruby is
expensive and stained spots are invisible with the naked eye unless
viewed under an ultraviolet or blue light source, making manual
spot excision more hazardous and cumbersome (97). Quinn
and co-workers developed a 2D-PAGE proteome profile of
normal and diabetic rat retina. After SYPRO Ruby staining and
imaging,gelswereagainstainedwithCoomassieBlueaidingmanual
removalofprotein spotsfromthegels.However, sinceCoomassieis
less sensitive fewer spots were subsequently stained (66).
Deep Purple is a fluorescence-based stain which has been
reportedtobemoresensitivethanSyproRubyalthoughbackground
fluorescence and photoinstability are limiting factors (80, 98, 99).
4.2. Protein Labelling
for 2D-DIGE
First described in 1997 (100), 2D fluorescence difference gel elec-
trophoresis (DIGE) is a version of 2D-PAGE where the proteins
in the sample are labelled prior to electrophoresis so avoiding the
need for staining (101–105). DIGE chemistry relies on the tag-
ging of lysine and cysteine with minimal and saturation fluores-
cent cyanine dyes respectively (Fig. 2). The minimal labelling
strategy labels only around 5% of lysine residues thus limiting
any decrease in protein solubility, apparent increase in molecular
mass (105, 106) and interference with subsequent tryptic cleavage
(discussed later). 2D-DIGE can offer sensitivity up to 0.5 fmol of
protein, a broad linear dynamic range of four orders of magni-
tude, and labelling that does not interfere with subsequent iden-
tification by MS (101, 102). One of the great advantages of this
system is that up to three samples can be run on the same gel si-
multaneously, thereby reducing the number of gels needed. The
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specific excitation and emission wavelengths of the dyes. An inter-
nal standard, made from a pooling of all the samples in the exper-
iment, comprises one of the three samples on the gel. The internal
standard is labelled with Cy 2 for example and run together with
individual experimental and control samples which are labelled
with the other dyes (e.g. Cy 3 or Cy 5). Therefore, every protein
from each of the samples is represented on the internal standard to
which it can be compared and relative quantitation calculated.
Since the internal standard is normalised across all the gels, sepa-
ration of inter-gel experimental variation from biological variation
is possible (11, 102).
Inall,2D-DIGEoffersamorereliableandreproduciblemethod
of relative protein quantitation (107). Proteins with a higher abun-
Fig. 2. Typical 2D-DIGE workflow for comparative expression proteomics. The samples are labelled
by fluorescent dyes (Cy 2, 3 and 5) and combined together prior to the IEF. The scanned fluorescent
images are analysed by DeCyder™ analysis software using the normalisation by Cy2-labelled pool
sample. The protein spots (e.g., crystallin mu) with statistical significance that express different ex-
pression profiles between the two groups are further analysed by MALDI-TOF-MS. The peptide
mass fingerprint of crystallin (mu) shows the peptides marked with ‘*’ matched to MASCOT search
against the NCBInr primate database. The x- and y-axes show the mass to changed (m/z) ratio and
the % abundance of the tryptic peptide fragments, respectively. Also depicted in the inset for crys-
tallin (mu) mass spectrum is the representative 3-D protein-expression profiles for the two groups.
Typically, the most-abuntant peptide fragment is sequenced by, additive series of the y- and b-ions
generated as well as the immonium ions, MALDI-TOF-TOF (e.g., peptide fragment with m/z of
1,667.8) to confirm the identification of protein and charactirise the sites of PTM. Reprinted from
Tannu and Hemby (22) with permission of Elsevier.
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labelledmoreheavilythanproteinswithfewerlysinegroupsirrespec-
tive of true protein amount. However, since protein spot intensity is
relatedtotheintensityofthecorrespondingspotintheinternalstan-
dard this will not pose a problem with regard to relative protein
quantitation (103, 107). A potential drawback which follows with
t h ed e p e n d e n c eu p o nas p e c i f i ca m i n oa c i df o rt a g g i n gi st h a ti n
theabsenceoflysinenolabellingwilloccur(11).Anotherimportant
consideration is that labelled proteins are approximately 0.5 kDa
higher in molecular mass leading to slightly different positions on
the2D-gelscomparedtotheunlabelled(11).Sinceonlyasmallper-
centage of proteins are labelled it should be the unlabelled protein
thatisexcisedformassspectrometricanalysis.Toensurethis,further
staining of the gel following 2D-electrophoresis with another agent
such as silver nitrate or SYPRO Ruby is necessary for spot picking
and cutting, especially for lower molecular mass proteins (11,
106). Protein labelling of cysteine residues at saturating conditions
inthefirstinstancemayalsobeconsideredtoavoidthisextrastaining
step. However, since the dyes react with cysteine rather than lysine
residues the gelimage can appearquite differentdue tothe differing
amountsoftheseaminoacids.Inaddition,theapproximately13%of
eukaryotic proteins that do not contain cysteine residues will not be
labelled (11). Furthermore, the DIGE system (GE Healthcare)
requires specialised reagents, scanners and software that may not
be affordable for many laboratories; however, it is an effective pro-
teomic tool that continues to be applied in ophthalmic research
(38, 68, 108–111).
Fort et al. (68) used2D-DIGEandiTRAQ(coveredlater)pro-
teomictechniquesaswellasimmunologicalandgeneticexperiments
to characterise the protein changes in the retina of Sprague–Dawley
diabetic rats receiving no insulin and those treated with a combina-
tionof different insulin regimens comparedwith controls over time.
Diabetes was induced in this rat model by intraperitoneal injection
with streptozotocin. During sample preparation, lipids and nucleic
acids were removed from the retinal samples by precipitation using
The 2D-Cleanup Kit (GE Healthcare). Samples underwent IEF
(pH 3–10) and second dimension separation upon 10% polyacryl-
amide gels. SYPRO Ruby staining was used for spot picking follow-
ingelectrophoresis.Analysisofthe2D-DIGEexperimentsuponthe
8-week diabetic rat retinas compared with age-matched controls
with or without treatment revealed over 30 differentially expressed,
mostly decreased, protein spots. The nine spots that were increased
in expression were located in the same region upon the 2D-gel and
identified as different crystalline proteins or isoforms by mass spec-
trometry (MALDI-MS/MS). The increased crystalline expression
was confirmed with iTRAQ analysis and further characterised with
immunoblotting, immunohistochemistry and real-time RT-PCR
related to the time course and treatment of the induced diabetes.
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human vitreous affected with PDR. Affinity chromatography
was used to remove albumin and IgG (GE Healthcare) from
the vitreous samples that were further purified by acetone
precipitation. Approximately 1,400 protein spots were resolved of
which 41 were found to be greater than 1.4-fold differentially
expressed.
5. 2D-Page Image
Acquisition
and Analysis
Prior to post-experimental quantitative analysis, a digitised image
of the gel is required. There is a range of devices available with the
most commonly used being a densitometer, camera system, phos-
phor imager or fluorescence scanner.
Detailed evaluation of the scanned images is made possible by
a variety of computer image analysis software packages. The so-
phisticated algorithms allow the comparative analysis and storage
of the complex 2D-gel data. Some of the most commonly used
programmes at the present time include PDQuest (Bio-Rad,
USA), Image Master 2D Platinum (GE Healthcare), Delta2D
(DECODON, Germany) and Progenesis SameSpots (Nonlinear
Dynamics, USA). The latter is compatible with both 2D-PAGE
and 2D-DIGE. Each programme has its advantages and disadvan-
tages, and direct comparisons between them can be difficult (96,
112–115).
The general working principles of analysis in a classical 2D-
PAGE approach involves the comparison of thousands of proteins
between different groups to find those that are differentially
expressed. Typically, the first step is noise reduction, by correcting
the raw image data and accurately subtracting the gel back-
ground. Spots are then detected, volumes normalised to correct
for experimental variances, followed by inter-gel matching and
relative quantitation. A reference or master gel is chosen to which
all other gels are compared. If the matching of spots is inaccurate
conclusions about their differential expression cannot be drawn.
To fulfil the gold standard of analysis, manual editing and verifi-
cation of the matched spots is generally required, which can be
very time consuming. With this in mind the Progenesis software
programmes were designed to offer superior automation of spot
detection and matching. Indeed, Progenesis Workstation has
shown comparable results to PDQuest’s more manual approach,
but only when spots are well resolved (114). A standardised eval-
uation test of the various analysis programmes has yet to be devel-
oped (105).
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Identification
and Verification
Afterestablishingthedifferentialexpressionoftheproteinspotsthey
c a nb ee x c i s e df r o mt h eg e la n dp r o c e s s e df o ri d e n t i f i c a t i o n .G e l
excisioncanbeperformedmanuallyorbywayofan automated cut-
ter. Some of the analysis software tools, for example PDQuest, can
be integrated with an automated gel cutter to increase throughput
and accuracy. The excised protein spots can be characterised by a
number of means such as Edman sequencing and amino acid com-
position (88, 116); however, MS is the method of choice (11, 117).
There have been many great advances in MS over the years,
consolidating its position as the leading technology in the identifica-
tion and characterisation of proteins within biological systems (117–
120). Indeed, MS is a highly sensitive and rapid technique for the
identification of proteins that have previously undergone separation
commonly with 2D-PAGE. The proteins in the excised gel pieces
are usually digested to generate peptides for MS analysis, since ex-
traction of whole proteins from gels is inefficient (88). The peptides
recovered should be purified, since the detergents, salts and buffer
contaminants can interfere with MS. These substances can be re-
moved by various procedures including liquid chromatography
(14, 88). Trypsin, typically used in protein identification, is a serine
protease that cleaves proteins at the C terminus of lysine and argi-
nine residues except when followed by proline, thereby generating
a fingerprint of peptide masses with an average size of 800–2,000
Da that can be searched in databases or further sequenced by tan-
dem MS (21). This combination of mass spectrometric identification
of digested samples, with subsequent comparisons with established
databases is sometimes referred to as ‘bottom-up’ MS. In compari-
son, the novel and exciting ‘top-down’ approach involves the frag-
mentation of intact (non-digested) proteins within the mass
spectrometer, although this technique is not sufficiently developed
at present (119, 121).
There are several combinations of MS instrumentation avail-
able, each with its own set of advantages and limitations. Generally,
a mass spectrometer consists of an ion source, a mass analyser and a
detection system. The two main ways of volatising and ionising
proteins or peptides are matrix-assisted laser desorption ionisation
(MALDI) and electrospray ionisation (ESI). With MALDI, the
peptides/proteins are co-crystallised with a dry matrix on a plate.
The molecules are brought into an ionised gaseous phase by way
of a laser, which are subsequently analysed in the MS. The more
complex ESI analyses molecules in solution and it can therefore
be easily combined with liquid chromatography, thus providing
an additional separation technique prior to mass spectrometric
analysis (11). A range of mass analysers is commonly used: time-
Ocular Proteomics 77of-flight (TOF), quadrupole, ion trap, high-resolution orbitrap and
Fourier transform ion cyclotron resonance. Each one works differ-
ently, having their own strengths and weaknesses and can be used
alone or in combination (11, 117)( F i g .3).
Results from a proteomic experiment should not stand alone.
At least one confirmatory test is necessary, commonly western
blotting, immunohistochemistry or ELISA which all rely on anti-
body–antigen reactions. Western blotting aims to detect a specific
Fig. 3. Principlesofmassspectrometry.aMALDI-TOF mass spectrometer. The sample is co-crystallised
withmatrixmoleculesasadrysampleontheplate.Thepeptidesarebroughttoanionisedgasphasebya
laser pulse. b The ionised peptides are analys e di nt h et i m e - o f - f l i g h t( T O F )u n i ti nt h em a s ss p e c t r o m e t e r
givingapeptidemassfingerprint.cIfthesampleispureenough,thepeptidemassfingerprintcanbeused
to search DNA and protein databases for identification. d Tandem mass spectrometry (MS/MS) as
obtained by a Q-TOF mass spectrometer. The sample is ionised at atmospheric pressure byelectrospray
ionisation (ES source). The ions enter the vacuum system through the sampling cone and, in the quadru-
pole section ions, of a particular m/zare selected and fragmented in the collision cell. eIn the collision cell,
peptides are mainly fragmented at the peptide bonds producing b type (blue) and y type (red) ions. The
masses of the resulting peptide fragments are measured inthe TOF unit. fExampleofacollision-induced
spectrum with the amino acid sequence given as detected from the N-terminal (b type ions) and from the
C-terminal (y type ions). Reprinted from Honoré et al. (11) with permission of John Wiley & Sons, Inc. The
mass fingerprint (C) is reprinted from Honoré (134) with permission of Expert Reviews Ltd.
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lar mass, and provides semi-quantitative validation of the expres-
sion levels. Though the protein molecular mass is not apparent
with immunohistochemistry, this technique is able to show the
localisation of the protein within the cell and tissue architecture.
ELISA offers a more quantitative measurement of the protein
within the sample. However, the common difficulty encountered
with these immunological methods is commercially acquiring or
self-producing specific antibodies with a high affinity that work
well in the particular system used.
7. Alternative
Approaches
in Ocular
Proteomics
Non-gel-based MS offers an alternative way of studying ocular
proteomics (22). These include multi-dimensional protein identi-
fication technology (MuDPIT) (122), isotope-coded affinity tags
(ICAT) (123, 124), isobaric tags for relative and absolute quantita-
tion (iTRAQ) (125–127) and stable isotope labelling with amino
acids in cell culture (SILAC) (12, 128, 129).
The MuDPIT method capitalises on a protein’s/peptide’s
unique physical characteristics of charge and hydrophobicity by
utilising a LC system usually composed of a strong cation ex-
change and reverse phase chromatography column that is coupled
with MS and database searching. The system works upon the total
raw protein content of the sample that has usually been tryptically
digested. This has allowed more proteins at the extremes of pI
and molecular mass, as well as membrane proteins to be identi-
fied, all of which may be difficult for 2D-PAGE (122).
However, relative quantitation of protein expression between
samples can be difficult with the MuDPIT technique, something
that ICAT, iTRAQ and SILAC have attempted to address. ICAT
labels cysteine residues of proteins with one of two mass tags
differing by, e.g. 9 Da, whilst iTRAQ labels the N terminus of
all peptides, and lysine residues with tags of identical mass with
differing design (123, 125)( F i g .4). With SILAC, labelling of
proteins takes place during cell culture where one population of
cells are grown in a medium containing a ‘light’ amino acid and
another in a medium with a ‘heavy’ amino acid (128). This type
of chemical labelling of proteins (ICAT) and peptides (iTRAQ)
and metabolic labelling of proteins in cultured cells (SILAC)
results in differential ion intensities that can be detected by MS
for relative quantitation.
Allison and colleagues (124) undertook a study of the effects
of thyroid hormone on retinal development in a rainbow trout
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can act as markers of photoreceptor differentiation. However,
they found that these membrane bound proteins might not be
able to be reliably detected using 2D-PAGE. They therefore
opted to study the fish retina using ICAT and LC-ESI-MS/
MS. With this method, 1,684 unique peptides including those
of opsins were detected. Indeed, significant expression changes
were found with four of the five opsin classes of the rainbow
trout retina when comparing thyroid hormone-treated and un-
treated fish.
In another study, the levels of the anti-microbial protein
defensin (NP-2) were measured in a rabbit model of corneal inju-
ry using iTRAQ with LC-ESI-MS/MS (126). Tears were collect-
ed from the rabbits prior to injury and after corneal wounding
days 1–3. Each of the four 5-μL samples was labelled with differ-
ent iTRAQ reagents before being combined for analysis. As a fur-
ther control iTRAQ was also used to measure expression levels of
Fig. 4. Non-gel-based approach for analysis of expression proteomes. The most commonly used,
commercially available, quantitation methods coupled with the MDLC approaches of comparative
proteomics are depicted. The figure shows the ICAT and iTRAQ reagent structures. The peptide-
reactive group (PRG) covalently links iTRAQ as well as the ICAT reagent isobaric tag with the lysine
side chain and N-terminal group of peptide. The fragmentation shown with dashed lines occurs during
MS/MS. The balance group of the iTRAQ reagent undergoes neutral loss, and the resultant reporter
group (114–117) peaks in the low-mass region are used for relative quantitation. Reprinted from
Tannu and Hemby (22) with permission of Elsevier.
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previous studies to remain relatively constant before and after cor-
neal wounding. The levels of NP-2 increased after corneal wound-
ing and decreased as healing progressed, whilst lipophilin AL
remained stable throughout.
An et al. (129) used SILAC and LC-ESI-MS/MS to examine
the differential protein secretion of RPE cells in relation to drusen
and pathological changes of AMD. The authors obtained healthy
age-matched donor RPE cells with the wild-type complement
factor H (CFH) genotype, and AMD donor RPE cells with the
homozygous and heterozygous CFH genotype for culture in isoto-
pically unlabelled and heavy amino acids respectively (
13C6-Arg and
13C6,
15N2-Lys). This procedure identified many differentially
secreted proteins involved in tissue development, angiogenesis,
complement regulation and protein aggregation.
Choe et al. (130) compared the efficacy of 2D-PAGE using
SYPRORubystaining,withiTRAQandconcludedthatbothtechni-
ques had similar consistency in measurements (CV G31% 2D-PAGE
vs.G24%iTRAQ). Similarly, arecentstudyon human epithelial ovar-
ian cancer found that the combination of 2D-PAGE with SYPRO
Ruby staining and iTRAQ produced complimentary results (131).
A comparative study of 2D-DIGE, ICAT and iTRAQ showed
that all three techniques produced fairly accurate quantitative
results (132). The global tagging of iTRAQ offered better sensi-
tivity than the limited cysteine tagging of ICAT since more pep-
tides were detected for a given protein. Comigration of multiple
proteins into a single 2D-gel spot posed problems for spot bound-
ary and relative quantitation calculations with the DIGE tech-
nique. However, DIGE was found to have comparable
sensitivity with ICAT (132). DIGE incorporates a dynamic range
of four orders of magnitude where as in most cases MS is below
three orders of magnitude (101, 102). In addition, just as comigra-
tion of proteins upon the 2D-gel can cause quantitation problems,
a similar difficulty exists with MS-based quantitation due to over-
lapping signals from different ion species unless high-resolution
MS is used (102, 133). It is also important to note that the relative
quantitations made with 2D-DIGE are at the protein level, in con-
trast to MS where it is based on peptides. Furthermore, the use of
proteolysis to generate lower molecular mass peptides can lose essen-
tialinformationnecessarytodistinguishthedifferentproteinisoforms
arising from alternative splicing, PTM and proteolytic cleavage.
8. Closing
Remarks
The use of appropriate sample preparation is essential to ensure the
resultsobtained froma proteomic experimentare sound.The inves-
tigatormustbeclearonwhichtypeofocularsampleandproteinsare
Ocular Proteomics 81under scrutiny and apply the necessary preparatory steps. However,
it must be kept in mind that the addition of further sample prepara-
tionstepsmayimprovetheperceivedqualityoftheresultsinoneway
by reducing complexity, but possibly bias the outcome by causing
inadvertent, and perhaps irreproducible, loss of certain proteins.
Despite the technological advances, presently no strategy used
alone or in combination can detect, quantify and identify the enor-
mousproteinprofilepresenteveninasinglecelltype.However,the
current mass spectrometric-based proteomic techniques coupled
with or without gel electrophoresis, especially with targeted
approaches, hold the promise to further elucidate ocular disease
processes and lead to the discovery of strong novel biomarkers
and therapeutic targets useful in many ophthalmic conditions.
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